SUMMARY -Tropical spastic paraparesis (TSP) is
Tropical spastic paraparesis (TSP) is a chronic progressive myelopathy predominant in the tropics and Japan. In the tropical areas it has been described in Africa, India, Seychelles Islands, the Caribbean and Latin America 1 4 , 2 8 . In South America it was described for the first time by Zaninovic in 1981 in Colombia (Tumaco) 32 where a cluster of such patients exists. In Brazil, the first clinical cases were published in 1989 19 and since then Brazilian neurologists have enriched and increased the reports on it 1 -13. 15-19.21-27,29-31 This paper aims to do a perusal of the literature on TSP in Brazil and to point out the characteristics of the Brazilian TSP studies. Moreover it intends to analyze critically these papers in order to stimulate further studies on TSP in Brazil.
METHOLOGY
For this analysis we collected and analyzed the papers published by Brazilian authors in national and international journals. Despite exhaustive search for these papers it may happen, by chance, that some have not been included and for this we apologize their authors in advance.
RESULTS
Up to now around 29 papers have been published.They concern clinical, demographic, serological and therapeutical features of TSP (Table 1, Table 2 ). Among the TSP cases, their mean age was 43.8, with a slight predominance of females (149 women and 140 men) and 111 were white, 134 mulattoes and 27 blacks ( Table 3 ). These patients have been reported from only two regions of Brazil: Northeast (Ceará, Pernambuco, Bahia) and Southeast (São Paulo and Rio de Janeiro) ( Table  1) .
COMMENTS
The relation of HTLV-1 to many of TSP patients in some regions of Brazil supports the notion of the presence and endemicity of this virus in this country. However, the serological tests for HTLV-1 used in the different Brazilian series do not include, in all studies, complete screening and confirmatory tests ( Since 1989 an increasing interest has grown on TSP in Brazil and the papers are mainly concerned with its clinical and serological features.
The clinical descriptions lie mostly on the classical signs of the syndrome, namely the pyramidal signs present in all cases and the variable presence of sphincter and sensory disturbances (Table  4) 9,i7,i9,2i,24,3o Q n e Qf g 3 p S j n m j s ollnical analysis is the definition of the initial symptoms and the progression of the full picture. Only some papers give information of the mean evolution of the patients 9 1 7 1 9 * 2 1 . The studies on TSP in Brazil and elsewhere have not depicted the natural history of the condition and are only limited to notification of cases in a temporal segment of their evolution.
Nobody has yet followed up the patients longitudinally and this opens an interesting aspect in this research. Moreover, as far as the number of cases is concerned, some authors have a trend to repeat their series in different papers so that we cannot know what the exact number of patients they have. It is therefore necessary that the authors make explicit who is who in each other paper. In some papers there is also an interest on other neurological and systemic symptoms 9 * 23 . This may contribute to the understanding of the clinical spectrum of retroviral-bound conditions. This may be a promising step, but we should be aware to define exactly what is TSP clinically to prevent misdiagnosis of similar conditions.
From the demographic point of view, we call attention to the number of HTLV-1 negative TSP cases which reaches about 63.7% of the obscure myelopathies (Table 2) . Despite some series with predominance of negroes and mulattoes, other series also report an important number of white patients 9 * 17 * 29 . In many papers of Brazilian authors there is a lack of information on blood transfusion, sexually transmitted diseases, intravenous drug addiction, breast-weaning and homosexuality (Table  3) . Another gap resides on the territorial extent of TSP surveys in Brazil. The studies have been carried out in only some areas of Brazil and no data are so far available from South, Center and North Brazil. Only one paper has performed a familial study of TSP 1 6 and this represents a step for understanding of HTLV-1 transmission and spreading in Brazil.
A not-yet defined point is the etiological final definition of TSP. Since Gessain's report in lÇSS^on HTLV-1 related TSP there is an imperative posture to relate strictly this syndrome to HTLV-1 and all other TSP cases without this connexion are thought to be doubtful. This had led to misdiagnosis of other myelopathic conditions 31 . The retroviral etiology is nevertheless a very important clinical and epidemiological finding in TSP, because it is the first true and proven etiology for one of the obscure tropical myelopathies. However this should not block further etiological research for the negative cases.
The CSF profile of TSP patients has also been presented in some Brazilian series (Table 5) . Some papers have done it in a systematized way 9 1 1 , 2 2 , 2 9 and shown slight to moderate changes in cells, glucose, protein values and electrophoretic picture. Less expressive changes in HTLV-1 negative TSP patients help differentiating them, and are probably due to timing of viral activity 9 -29 .
Very few papers 8 , 2 5 are bound to therapeutical approaches of TSP patients. Therapeutical assays have produced unsucessful results with prednisolone and danazol and this still represents a challenging domain in this clinical entity.
As we have seen, many gaps exist in the different papers of Brazilian authors. One of the ways we may overcome such difficulties is the definition and use of a common clinical and demographic protocol such as this proposed by Dr. Abelardo Araújo from Fiocruz (personal communication). The use of this protocol in a multicentric national collaborative study will make possible a definition of the profile of the Brazilian TSP patients. Moreover analytical studies such as the one carried out recently in Salvador 22 , may also bring a contribution to define the association between myelopathy and HTLV-1.
